Search Results

Showing results 9931 - 9940 for wcm library

15th Medical Complex Art Show Calls for Submissions | Newsroom | Weill Cornell Medicine

...News from WCM Related News Skin-to-Skin Contact Associated with Brain Changes in Preterm Infants...

https://news.weill.cornell.edu/news/2005/08/15th-medical-complex-art-show-calls-for-submissions

Calling All Artists for the 16th Medical Complex Art Show (Sept. 19 Deadline) | Newsroom | Weill Cornell Medicine

...News from WCM Related News Skin-to-Skin Contact Associated with Brain Changes in Preterm Infants...

https://news.weill.cornell.edu/news/2006/08/calling-all-artists-for-the-16th-medical-complex-art-show-sept-19-deadline

Self-collapsing Feeding Tube with Cleaning Mechanism | Enterprise Innovation

...BioVenture eLab Center for Technology Licensing at Weill Cornell Medicine Weill Cornell Medicine in Qatar (WCM-Q...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/self-collapsing-feeding-tube-cleaning-mechanism

Treatment of Cardiac Disorder with Nicotinamide Riboside | Enterprise Innovation

...BioVenture eLab Center for Technology Licensing at Weill Cornell Medicine Weill Cornell Medicine in Qatar (WCM-Q...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/treatment-cardiac-disorder-nicotinamide-riboside

VEGF for the Treatment of Peripheral Nerve Damage | Enterprise Innovation

...BioVenture eLab Center for Technology Licensing at Weill Cornell Medicine Weill Cornell Medicine in Qatar (WCM-Q...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/vegf-treatment-peripheral-nerve-damage

Endoscopically Deployable Temporary Anti-Reflux Device | Enterprise Innovation

...BioVenture eLab Center for Technology Licensing at Weill Cornell Medicine Weill Cornell Medicine in Qatar (WCM-Q...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/endoscopically-deployable-temporary-anti-reflux

MicroRNA-708 as a Therapeutic Agent against Metastatic Breast Cancer | Enterprise Innovation

...BioVenture eLab Center for Technology Licensing at Weill Cornell Medicine Weill Cornell Medicine in Qatar (WCM-Q...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/microrna-708-therapeutic-agent-against-metastatic

Inhibitors of Fusion between Viral and Cell Membranes as well as Compositions and Methods of Using Them | Enterprise Innovation

...BioVenture eLab Center for Technology Licensing at Weill Cornell Medicine Weill Cornell Medicine in Qatar (WCM-Q...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/inhibitors-fusion-between-viral-and-cell-membranes

Nicotinamide Riboside for the Prevention and Treatment of Hearing Loss | Enterprise Innovation

...BioVenture eLab Center for Technology Licensing at Weill Cornell Medicine Weill Cornell Medicine in Qatar (WCM-Q...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/nicotinamide-riboside-prevention-and-treatment

Methods and Compositions for Making Animal Models of Cancer with Controllable Metastasis | Enterprise Innovation

...BioVenture eLab Center for Technology Licensing at Weill Cornell Medicine Weill Cornell Medicine in Qatar (WCM-Q...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/methods-and-compositions-making-animal-models

Showing results 9931 - 9940 for wcm library